The Beauty Health Company Statistics
Total Valuation
SKIN has a market cap or net worth of $167.83 million. The enterprise value is $365.92 million.
Important Dates
The last earnings date was Wednesday, March 12, 2025, after market close.
Earnings Date | Mar 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SKIN has 125.25 million shares outstanding. The number of shares has increased by 8.21% in one year.
Current Share Class | 125.25M |
Shares Outstanding | 125.25M |
Shares Change (YoY) | +8.21% |
Shares Change (QoQ) | +0.28% |
Owned by Insiders (%) | 8.55% |
Owned by Institutions (%) | 60.06% |
Float | 81.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.50 |
Forward PS | 0.54 |
PB Ratio | 3.23 |
P/TBV Ratio | n/a |
P/FCF Ratio | 10.91 |
P/OCF Ratio | 10.40 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 23.80 |
Financial Position
The company has a current ratio of 7.00, with a Debt / Equity ratio of 10.97.
Current Ratio | 7.00 |
Quick Ratio | 5.86 |
Debt / Equity | 10.97 |
Debt / EBITDA | n/a |
Debt / FCF | 36.95 |
Interest Coverage | -6.51 |
Financial Efficiency
Return on equity (ROE) is -52.34% and return on invested capital (ROIC) is -5.92%.
Return on Equity (ROE) | -52.34% |
Return on Assets (ROA) | -5.25% |
Return on Invested Capital (ROIC) | -5.92% |
Return on Capital Employed (ROCE) | -10.98% |
Revenue Per Employee | $434,713 |
Profits Per Employee | -$37,839 |
Employee Count | 769 |
Asset Turnover | 0.41 |
Inventory Turnover | 1.89 |
Taxes
Income Tax | -452,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.82% in the last 52 weeks. The beta is 0.84, so SKIN's price volatility has been lower than the market average.
Beta (5Y) | 0.84 |
52-Week Price Change | -69.82% |
50-Day Moving Average | 1.50 |
200-Day Moving Average | 1.60 |
Relative Strength Index (RSI) | 45.75 |
Average Volume (20 Days) | 742,257 |
Short Selling Information
The latest short interest is 8.58 million, so 6.85% of the outstanding shares have been sold short.
Short Interest | 8.58M |
Short Previous Month | 8.85M |
Short % of Shares Out | 6.85% |
Short % of Float | 10.57% |
Short Ratio (days to cover) | 11.22 |
Income Statement
In the last 12 months, SKIN had revenue of $334.29 million and -$29.10 million in losses. Loss per share was -$0.36.
Revenue | 334.29M |
Gross Profit | 182.30M |
Operating Income | -67.77M |
Pretax Income | -80.63M |
Net Income | -29.10M |
EBITDA | -34.09M |
EBIT | -67.77M |
Loss Per Share | -$0.36 |
Full Income Statement Balance Sheet
The company has $370.06 million in cash and $568.16 million in debt, giving a net cash position of -$198.10 million or -$1.58 per share.
Cash & Cash Equivalents | 370.06M |
Total Debt | 568.16M |
Net Cash | -198.10M |
Net Cash Per Share | -$1.58 |
Equity (Book Value) | 51.80M |
Book Value Per Share | 0.41 |
Working Capital | 408.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $16.13 million and capital expenditures -$756,000, giving a free cash flow of $15.38 million.
Operating Cash Flow | 16.13M |
Capital Expenditures | -756,000 |
Free Cash Flow | 15.38M |
FCF Per Share | $0.12 |
Full Cash Flow Statement Margins
Gross margin is 54.53%, with operating and profit margins of -20.27% and -8.70%.
Gross Margin | 54.53% |
Operating Margin | -20.27% |
Pretax Margin | -8.84% |
Profit Margin | -8.70% |
EBITDA Margin | -10.20% |
EBIT Margin | -20.27% |
FCF Margin | 4.60% |
Dividends & Yields
SKIN does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -8.21% |
Shareholder Yield | -8.21% |
Earnings Yield | -17.34% |
FCF Yield | 9.16% |
Analyst Forecast
The average price target for SKIN is $2.50, which is 86.57% higher than the current price. The consensus rating is "Hold".
Price Target | $2.50 |
Price Target Difference | 86.57% |
Analyst Consensus | Hold |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SKIN has an Altman Z-Score of 0.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.11 |
Piotroski F-Score | 6 |